FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements

FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing